Ciprofloxacin Patent Expiration
Ciprofloxacin is Used for treating ear infections and inflammation in both pediatric and adult patients. It was first introduced by Bayer Healthcare Pharmaceuticals Inc
Ciprofloxacin Patents
Given below is the list of patents protecting Ciprofloxacin, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Otiprio | US11246863 | Ciprofloxacin otic composition and kits and method for using same | Nov 27, 2038 | Alk Abello |
Otiprio | US11040004 | Otic gel formulations for treating otitis externa | Nov 12, 2037 | Alk Abello |
Otiprio | US9220796 | Sterilization of ciprofloxacin composition | Jul 01, 2035 | Alk Abello |
Otiprio | US8318817 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | Apr 27, 2030 | Alk Abello |
Otiprio | US9233068 | Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders | Dec 11, 2029 | Alk Abello |
Otiprio | US11369566 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | Apr 21, 2029 | Alk Abello |
Otiprio | US9205048 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | Apr 21, 2029 | Alk Abello |
Otiprio | US9603796 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | Apr 21, 2029 | Alk Abello |
Cipro |
US5695784 (Pediatric) | Flavor-masked pharmaceutical compositions |
Jun 09, 2015
(Expired) | Bayer Hlthcare |
Cipro | US5695784 | Flavor-masked pharmaceutical compositions |
Dec 09, 2014
(Expired) | Bayer Hlthcare |
Cipro |
US6136347 (Pediatric) | Flavor-masked pharmaceutical compositions |
Jul 06, 2013
(Expired) | Bayer Hlthcare |
Cipro | US6136347 | Flavor-masked pharmaceutical compositions |
Jan 06, 2013
(Expired) | Bayer Hlthcare |
Ciprofloxacin's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List